SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF ‐2α signaling pathway in arrhythmogenic cardiomyopathy

Yang, Zhe, Li, Tengling, Xian, Jianzhong · The FASEB Journal · 2022